2018
DOI: 10.1016/j.jecr.2018.07.003
|View full text |Cite
|
Sign up to set email alerts
|

Case of reversible diabetes mellitus in the setting of benign pheochromocytoma

Abstract: Pheochromocytomas have been shown to impair glucose tolerance and, rarely, to precipitate overt diabetes mellitus. We report here a case of a large pheochromocytoma in a woman with a recent diagnosis of diabetes mellitus that proved difficult to control despite high-dose insulin therapy who had complete resolution of her hyperglycemia following adrenalectomy. Her dramatic presentation demonstrates the need to consider this etiology in patients with new-onset insulin resistance and hypertension.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
7
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(8 citation statements)
references
References 17 publications
1
7
0
Order By: Relevance
“…This was not the case of our patient who had sustained severe hypertension associated with the classic symptoms of pheochromocytoma (palpitation, sweating, and hot flashes), hypokalemia, and a secondary diabetes mellitus. In our case, as reported in the literature [ 16 , 17 ], a remarkable remission of diabetes mellitus and an improvement of lipid profile were noticed after tumor removal confirming the secondary character of these two metabolic disorders. In fact, catecholamine excess affects insulin secretion, decreased glucose uptake in the peripheral tissues, and increased insulin resistance leading to impaired fasting glucose or overt diabetes mellitus [ 18 ].…”
Section: Discussionsupporting
confidence: 88%
See 1 more Smart Citation
“…This was not the case of our patient who had sustained severe hypertension associated with the classic symptoms of pheochromocytoma (palpitation, sweating, and hot flashes), hypokalemia, and a secondary diabetes mellitus. In our case, as reported in the literature [ 16 , 17 ], a remarkable remission of diabetes mellitus and an improvement of lipid profile were noticed after tumor removal confirming the secondary character of these two metabolic disorders. In fact, catecholamine excess affects insulin secretion, decreased glucose uptake in the peripheral tissues, and increased insulin resistance leading to impaired fasting glucose or overt diabetes mellitus [ 18 ].…”
Section: Discussionsupporting
confidence: 88%
“…In most published cases, the mean age at presentation was about 30 years, but very young cases have been described, the youngest before 5 years [ 7 , 10 ]. In addition, VHL-associated pheochromocytomas are less likely to be associated with symptoms or biochemical evidence of catecholamines production compared with those occurring in patients without VHL [ 16 , 17 ]. In a report of the National Institute of Health about 64 patients with VHL disease and pheochromocytomas, a total of 106 tumors were identified.…”
Section: Discussionmentioning
confidence: 99%
“…2019 18 36 IU insulin (insulin detemir 24 IU/day, insulin aspart 12 IU TID) None Left, unilateral and benign SDH-A gene Cha J, et al. 2018 19 154 IU insulin (insulin glargine 68 IU/day, insulin aspart 28 IU TID) None Left, unilateral and benign SDH-B gene Mesmar B, et al. 2017 15 Case 1: Insulin 45 IU/day Metformin Left, unilateral and benign No genetic testing was performed Case 2: Insulin 70 IU/day Metformin + glipizide Left, unilateral and benign Hirai H, et al.…”
Section: Discussionmentioning
confidence: 99%
“…Several case reports have reported cardiomyopathy [ 4 6 ], pulmonary edema [ 7 ], and hyperglycemia [ 8 ] as isolated complications of pheochromocytoma. However, the concomitant presence of all these complications along with multi-organ failure made the diagnosis and management particularly challenging in this patient.…”
Section: Discussionmentioning
confidence: 99%